A Senate working group is already crafting an entirely new version of a replacement for the Affordable Care Act. House Speaker Paul Ryan waited on a new CBO score to make sure the American Health Care Act met necessary savings targets to use the budget reconciliation process to undo Obamacare.
Researchers from the University of Wisconsin devised a phone-based intervention to assist patients during the transition from hospital to home following complex abdominal surgery and reduce readmissions.
James D. Chambers, PhD, MPharm, MSc, of Tufts Medical Center was named the 2017 recipient of the Bernie J. O'Brien New Investigator Award at the ISPOR 22nd Annual International Meeting. He highlights the trends he is most looking forward to seeing develop over the next year and the next 5 years.
Gene therapies have tremendous potential. They are a short treatment that could have lifelong effects. However, the very expensive therapies have a lot of unknowns and raise a number of ethical and practicality questions.
Cost-effectiveness thresholds can do more than just guide determinations on whether drugs have value, explained Patricia Danzon, PhD, professor at the Wharton School at the University of Pennsylvania. Using these thresholds as a requirement for reimbursement provides an incentive for research and development focused on producing new drugs that will be considered effective enough to pay for.
In the first weeks of his tenure as FDA commissioner, Scott Gottlieb, MD, is taking action on the issue he had vowed to make his “highest initial priority:” fighting the opioid abuse epidemic and stopping the waves of overdoses across the nation.
The proposed cuts would come just as CMS is gearing up to launch the Diabetes Prevention Program in Medicare starting in January 2018. Diabetes accounts for $1 of every $3 spent in Medicare, and CMS has been looking for ways to slow the number of beneficiaries who develop the disease.
The notion of letting Medicare negotiate drug prices has been around for years, but has recently gained new traction under President Donald Trump. Panelists at the ISPOR 22nd Annual International Meeting, held May 20-24 in Boston, Massachusetts, discussed the complexities of allowing Medicare to negotiate prices and whether or not it would produce meaningful savings.
COPD Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium